Argentys to Develop Agentic AI Pilot for Protein Informatics
Rockville, Maryland – March 10, 2026 – Argentys has announced the research version of AI-powered platform (Argentys Bio) that enables de novo antibody creation, computational affinity maturation, and developability-driven candidate selection from client-provided antigen sequences or structures.
